Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

View source ↗

Summary

Clinical trial update indicating bulvertide is being studied for its effects on bile acids and gut microbiota in patients with Hepatitis D, with recruitment ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bulvertide

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: HBV, HBV Coinfection | Status: RECRUITING